教育
- University of Wisconsin at Madison, M.S.P.H.
- University of Wisconsin Hospital and Clinics, Fellowship
- University of Cincinnati, Pharm.D.
- The Buffalo General Hospital, Residency
- State University of New York at Buffalo, B.S.
COURSES TAUGHT AT ACPHS
- 药物信息
- Pathophysiology, Therapeutics, Pharmacology and Medicinal Chemistry (PTP&M) - GI/营养
- Ambulatory Care clerkship in Gastroenterology/Hepatology (Advance 药房实践 Experience)
- Drug Policy Development clerkship (Advance 药房实践 Experience)
研究资助
- Co-Principal Investigators: 温顺的PD, Rosenberg M. Patterns of Utilization of Infliximab and Impact on Direct Medical and Indirect Costs in Individuals Diagnosed with Inflammatory Bowel Disease. Society of Actuaries. 2007年8月.
技术报告
- 温顺的PD, Shah ND, Van Houten H, Gumustop B, Rosenberg M. Infliximab Therapy for Individuals with Crohn's Disease: Analysis of Health Care Utilization and Expenditures. [Online] 29 January 2009.
教科书的章节
- 温顺的PD, Renaud-Mutart AC, Cosler LE. 第14章. Comparative Effectiveness. Health Economics and Outcomes Assessment. 1日美国东部时间. Sudbury, MA: Jones and Bartlett Publishers.
- 温顺的PD. Recent Concepts in the Treatment of the Irritable Bowel Syndrome. 药物治疗 Self-assessment Program. 4日美国东部时间. Kansas City, MO: American College of Clinical Pharmacy, 2003:71-97.
- 温顺的PD, Steinkellner A. 第五章. Use and evaluation of Pharmaceoconomics from the payers’ perspective. Introduction to Applied Pharmacoeconomics. 编辑:F. Randy Vogenberg 2000:81-108
SELECTED 出版物 AND 摘要
出版物
Hoffman JM, 温顺的PD, Touchette DR, Vermeulen LC, Schumock GT. Transparent and reproducible reports of economic evaluations of clinical pharmacy services: a goal for the future? (信) Am J Health Syst Pharm 2009;66:442-443.
Perez A, Doloresco F, Hoffman JM, 温顺的PD, Touchette DR, Vermeulen LC, Schumock GT. Economic evaluations of clinical pharmacy services: 2001-2005.药物治疗 2008; 28(11):285e-323e.
Shah ND, Chitkara DK, Locke GR, 温顺的PD, Talley NJ. Ambulatory care for constipation in the United States, 1993-2004. Am J Gastroenterol 2008;103:1746-53.
Schumock GT, Butler MG, 温顺的PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996-2000.药物治疗 2003;23:113-32.
Boissonnault WG, 温顺的PD. Risk factors for anti-inflammatory-drug- or aspirin-induced gastrointestinal complications in individuals receiving outpatient physical therapy services. J Orthop Sports Phys Ther 2002;32:510-7.
Haas SA, Jehn LR, 温顺的PD. Regional variation in stroke mortality in Wisconsin, 1989-1998. WMJ 2002;101:28-31.
艾略特我, 温顺的PD, Kanous问, 希尔GR, Weinswig PA, Bohlman摩根大通, Zimpel CL, 詹森公元前, 沃尔特斯博士, 萨特SL, 彼得森的, 彼得森RM, Binkley数控. Pharmacy-based bone mass measurement to assess osteoporosis risk. 安Pharmacother2002;36:571-7.
摘要
温顺的PD, Renaud-Mutart AC, Cosler LE. Electronic medical record use and warfarin drug-drug interactions during ambulatory visits in the United States, 2003-2006.Value Health 2009 May;12(3):A158. Presented at the 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes 研究, 5月20日, 2009, 奥兰多, FL.
Shah ND, Locke GR, 温顺的PD, Chitkara DK, Talley NJ. Ambulatory Care for Constipation in the United States, 1993-2004. Presented at the Annual Scientific Meeting of The American College of Gastroenterology, 10月20- 25日, 2006, 拉斯维加斯, NV.
温顺的PD, Rosenberg M, Shah ND, Gumustop B. Use of Infliximab for Ulcerative Colitis in the Pre-ACT I/II Era: An Analysis of Commercial Insurance Claims. Presented at Digestive Disease Week Meeting, May 24, 2006. 洛杉矶，加州.
温顺的PD, Shah ND, Rosenberg M, Van Houten HK. Comparing alternative propensity score methods: Measuring resource use after initiating infliximab treatment in Crohn’s disease. Presented at the Annual Meeting of the Society for Medical Decision Making, October 17, 2006. 剑桥,麻.
CONFERENCES AND PRESENTATIONS
Kane T, Boyd J, Obos L, Meek P. Raising the Bar for Student Performance in a 6-semester Pharmacy Skills Sequence. AACP Annual Meeting, Boston MA, July 21-23, 2018.